Published in Philos Trans R Soc Lond B Biol Sci on March 29, 2000
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol (2001) 3.40
Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol (2002) 3.21
Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol (2002) 1.75
Boosting immunity by antiviral drug therapy: a simple relationship among timing, efficacy, and success. Proc Natl Acad Sci U S A (2003) 1.15
Disentangling the interaction among host resources, the immune system and pathogens. Ecol Lett (2013) 1.10
Differential clearance and immune responses to tick cell-derived versus macrophage culture-derived Ehrlichia chaffeensis in mice. Infect Immun (2006) 1.08
Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus. Philos Trans R Soc Lond B Biol Sci (2000) 0.95
Immune response and virus population composition: HIV as a case study. Proc Biol Sci (2002) 0.93
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature (2016) 0.86
Host factors influencing viral persistence. Philos Trans R Soc Lond B Biol Sci (2000) 0.85
Virus replication strategies and the critical CTL numbers required for the control of infection. PLoS Comput Biol (2011) 0.81
Costs versus benefits: best possible and best practical treatment regimens for HIV. J Math Biol (2007) 0.79
Dynamics of recurrent viral infection. Proc Biol Sci (2006) 0.78
Cytotoxic T-lymphocyte memory, virus clearance and antigenic heterogeneity. Proc Biol Sci (2001) 0.77
Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors. Sci Rep (2016) 0.75
Modeling T cell responses to antigenic challenge. J Pharmacokinet Pharmacodyn (2014) 0.75
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science (1997) 15.09
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
Cytotoxic T-cell memory without antigen. Nature (1994) 6.55
Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med (1981) 5.82
Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (1994) 5.49
T cell memory. Annu Rev Immunol (1998) 5.20
Antigenic diversity thresholds and the development of AIDS. Science (1991) 5.13
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol (1994) 4.34
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.74
Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61
Population dynamics of immune responses to persistent viruses. Science (1996) 3.49
CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol (1996) 3.39
Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts. J Exp Med (1996) 3.26
On immunological memory. Annu Rev Immunol (1996) 3.21
T cell memory is short-lived in the absence of antigen. J Exp Med (1991) 3.16
Is T-cell memory maintained by crossreactive stimulation? Immunol Today (1990) 3.13
Lymphocyte life-span and memory. Science (1994) 2.99
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol (1999) 2.89
Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol (1998) 2.73
On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A (1996) 2.55
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest (1999) 2.42
The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med (1994) 2.40
Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci U S A (1997) 2.23
Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med (1992) 2.22
CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med (1996) 2.21
Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J Immunol (1996) 2.21
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A (1997) 2.20
Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory. Immunol Rev (1996) 2.11
On the cellular basis of immunological T cell memory. Immunity (1995) 1.92
Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol Rev (1997) 1.78
Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol (1998) 1.77
T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J Exp Med (1989) 1.76
Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J Virol (1992) 1.66
Germinal centers and antibody production in bone marrow. Immunol Rev (1992) 1.55
A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur J Immunol (1997) 1.52
Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol (1994) 1.51
The provocation of latent lymphocytic choriomeningitis virus infections in mice by treatment with antilymphocytic serum. J Exp Med (1968) 1.46
On T cell memory: arguments for antigen dependence. Immunol Rev (1996) 1.35
Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol (1993) 1.35
Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J Immunol (1997) 1.33
The numbers game for virus-specific CD8+ T cells. Science (1998) 1.28
Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J Infect Dis (1999) 1.27
Immune exhaustion: driving virus-specific CD8+ T cells to death. Trends Microbiol (1993) 1.20
CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J Immunol (1998) 1.17
Immunology. Memories are made of this? Nature (1994) 1.16
The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand J Immunol (1994) 1.14
Dynamics of cytotoxic T-lymphocyte exhaustion. Proc Biol Sci (1998) 1.03
Aspects of cytotoxic T cell memory. Immunol Rev (1996) 0.98
Comparison of the sensitivity of in vivo and in vitro assays for detection of antiviral cytotoxic T cell activity. Cell Immunol (1993) 0.97
Dynamics of macrophage and T cell infection by HIV. J Theor Biol (1999) 0.97
A simple relationship between viral load and survival time in HIV-1 infection. Proc Natl Acad Sci U S A (1999) 0.92
The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus. Immunology (1988) 0.92
The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV. Proc Biol Sci (1998) 0.88
Immune protection vs. immunopathology vs. autoimmunity: a question of balance and of knowledge. Brain Pathol (1993) 0.79
Cell mediated immunity in virus infections. Biosci Rep (1997) 0.79
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A (1997) 13.47
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med (1997) 12.26
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
Fairness versus reason in the ultimatum game. Science (2000) 6.19
Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr Biol (1994) 6.17
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol (1998) 5.05
Reward and punishment. Proc Natl Acad Sci U S A (2001) 4.10
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol (1997) 3.79
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
Virus dynamics and drug therapy. Proc Natl Acad Sci U S A (1997) 3.63
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses (1998) 3.40
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol (2001) 3.40
Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques (1993) 3.36
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med (1998) 3.19
Identification of highly attenuated mutants of simian immunodeficiency virus. J Virol (1998) 2.94
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med (1999) 2.77
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. J Virol (1999) 2.69
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol (1999) 2.65
Coinfection and the evolution of parasite virulence. Proc Biol Sci (1995) 2.59
Causes of HIV diversity. Nature (1995) 2.48
Quantifying the kinetic parameters of prion replication. Biophys Chem (1999) 2.46
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A (1999) 2.45
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol (2000) 2.24
Pre-existence and emergence of drug resistance in HIV-1 infection. Proc Biol Sci (1997) 2.15
The population dynamics of vertically and horizontally transmitted parasites. Proc Biol Sci (1995) 2.10
High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol (1999) 2.08
Human immunodeficiency virus drug therapy and virus load. J Virol (1997) 2.05
A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons. Proc Natl Acad Sci U S A (2000) 2.01
Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. AIDS Res Hum Retroviruses (1998) 1.97
Evolutionary preservation of redundant duplicated genes. Semin Cell Dev Biol (1999) 1.96
Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med (1999) 1.96
Another battle of the sexes: the consequences of sexual asymmetry in mating costs and predation risk in the guppy, Poecilia reticulata. Proc Biol Sci (1991) 1.95
MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med (2001) 1.81
Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc Natl Acad Sci U S A (1996) 1.79
Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol (2010) 1.78
Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci (2001) 1.77
A stain for myelin using solochrome cyanin. J Med Lab Technol (1965) 1.76
HIV results in the frame. Results confirmed. Nature (1995) 1.69
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A (1996) 1.68
Superinfection, metapopulation dynamics, and the evolution of diversity. J Theor Biol (1994) 1.68
The spatial ultimatum game. Proc Biol Sci (2000) 1.67
The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of alpha2delta subunits is key to trafficking voltage-gated Ca2+ channels. Proc Natl Acad Sci U S A (2005) 1.65
Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV. AIDS (1992) 1.65
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo. Eur J Immunol (2000) 1.61
Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol (2000) 1.57
The logic of contrition. J Theor Biol (1997) 1.54
Evolution of virulence in a heterogeneous host population. Evolution (2000) 1.53
Importance of the different beta subunits in the membrane expression of the alpha1A and alpha2 calcium channel subunits: studies using a depolarization-sensitive alpha1A antibody. Eur J Neurosci (1997) 1.52
Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol (1994) 1.51
The frequency of resistant mutant virus before antiviral therapy. AIDS (1998) 1.51
Evolutionary origins and maintenance of redundant gene expression during metazoan development. Trends Genet (1997) 1.50
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS (1993) 1.48
Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci U S A (1991) 1.48
Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication. J Virol (2000) 1.47
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res Hum Retroviruses (1998) 1.46
Evidence for two concentration-dependent processes for beta-subunit effects on alpha1B calcium channels. Biophys J (2001) 1.45
The continuous prisoner's dilemma: I. linear reactive strategies. J Theor Biol (1999) 1.45
In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail. J Virol (2001) 1.45
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS (1990) 1.44
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Adv Exp Med Biol (1996) 1.44
Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo. J Virol (1999) 1.43
Antigenic variation and the within-host dynamics of parasites. Proc Natl Acad Sci U S A (1996) 1.43
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses (1995) 1.42
Dissecting x-ray-emitting gas around the center of our galaxy. Science (2013) 1.41
Dynamics of immune escape in HIV infection. Wien Klin Wochenschr (1999) 1.40
Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet (1994) 1.40
Wealth condensation in pareto macroeconomies. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.38
Tides of tolerance. Nature (2001) 1.35
Adherence and drug resistance: predictions for therapy outcome. Proc Biol Sci (2000) 1.34
CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle. Proc Natl Acad Sci U S A (1989) 1.30
Identification of residues in the N terminus of alpha1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma. J Neurosci (1999) 1.29
Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol (2001) 1.29
Alpha 4 integrin directs virus-activated CD8+ T cells to sites of infection. J Immunol (1995) 1.28
Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection. J Virol (2001) 1.27
Dominant-negative synthesis suppression of voltage-gated calcium channel Cav2.2 induced by truncated constructs. J Neurosci (2001) 1.27
A generalized adaptive dynamics framework can describe the evolutionary Ultimatum Game. J Theor Biol (2001) 1.25
Intra-host versus inter-host selection: viral strategies of immune function impairment. Proc Natl Acad Sci U S A (1994) 1.25
Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J Virol (2001) 1.24
Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol (2000) 1.24
Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet (1984) 1.22
Calcium channel beta subunit promotes voltage-dependent modulation of alpha 1 B by G beta gamma. Biophys J (2000) 1.21
HIV-1 evolution and disease progression. Science (1996) 1.20